| 14th Feb 2025 5:05 pm |
RNS |
Holding(s) in Company |
| 13th Feb 2025 4:12 pm |
RNS |
Holding(s) in Company |
| 13th Feb 2025 2:52 pm |
RNS |
Holding(s) in Company |
| 12th Feb 2025 7:00 am |
RNS |
Strategic Platform License with TG Therapeutics |
| 7th Feb 2025 7:00 am |
RNS |
Notice of Results |
| 4th Feb 2025 7:00 am |
RNS |
Total Voting Rights |
| 31st Jan 2025 3:18 pm |
RNS |
Exercise of options and PDMR dealing |
| 30th Jan 2025 7:00 am |
RNS |
MaxCyte® Acquires SeQure Dx |
| 29th Jan 2025 3:05 pm |
RNS |
Holding(s) in Company |
| 22nd Jan 2025 2:25 pm |
RNS |
Holding(s) in Company |
| 21st Jan 2025 9:13 am |
RNS |
Holding(s) in Company |
| 17th Jan 2025 1:15 pm |
RNS |
Holding(s) in Company |
| 15th Jan 2025 4:00 pm |
RNS |
Holding(s) in Company |
| 13th Jan 2025 8:05 am |
RNS |
Preliminary Fourth Quarter and Full Year Results |
| 2nd Jan 2025 5:53 pm |
RNS |
Total Voting Rights |
| 31st Dec 2024 7:00 am |
RNS |
Exercise of options and PDMR dealing |
| 23rd Dec 2024 7:00 am |
RNS |
MaxCyte Announces Retirement of Board Member |
| 19th Dec 2024 4:26 pm |
RNS |
Holding(s) in Company |
| 18th Dec 2024 3:31 pm |
RNS |
Holding(s) in Company |
| 10th Dec 2024 5:16 pm |
RNS |
Holding(s) in Company |
| 10th Dec 2024 5:12 pm |
RNS |
Holding(s) in Company |
| 9th Dec 2024 7:00 am |
RNS |
MaxCyte Streamlines Operations and Raises Guidance |
| 2nd Dec 2024 5:09 pm |
RNS |
Total Voting Rights and Block Listing Return |
| 28th Nov 2024 3:05 pm |
RNS |
Holding(s) in Company |
| 28th Nov 2024 3:05 pm |
RNS |
Holding(s) in Company |
| 19th Nov 2024 9:49 am |
RNS |
Holding(s) in Company |
| 7th Nov 2024 7:00 am |
RNS |
Filing of 10Q form |
| 7th Nov 2024 7:00 am |
RNS |
Third Quarter 2024 Financial Results |
| 6th Nov 2024 1:43 pm |
RNS |
Exercise of options and PDMR dealing |
| 4th Nov 2024 1:23 pm |
RNS |
Total Voting Rights |
| 31st Oct 2024 7:00 am |
RNS |
Exercise of options and PDMR dealing |
| 18th Oct 2024 9:24 am |
RNS |
Grant of Options and Restricted Stock Units |
| 15th Oct 2024 1:05 pm |
RNS |
MaxCyte Appoints Cynthia Collins to Board |
| 11th Oct 2024 1:00 pm |
RNS |
Notice of Results |
| 10th Oct 2024 1:05 pm |
RNS |
MaxCyte Appoints Ali Soleymannezhad as CCO |
| 3rd Oct 2024 9:41 am |
RNS |
Exercise of options and PDMR dealing |
| 1st Oct 2024 9:47 am |
RNS |
Exercise of options and PDMR dealing |
| 1st Oct 2024 7:00 am |
RNS |
Total Voting Rights |
| 27th Sep 2024 4:15 pm |
RNS |
Holding(s) in Company |
| 27th Sep 2024 3:29 pm |
RNS |
Holding(s) in Company |
